Ryuta Shigefuku

8PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Oct 08, 2025
Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis.

Masahiko Tameda, Hideaki Tanaka, Yutaka Toyomasu

|Dec 12, 2024
A rare case of idiopathic portal hypertension with portopulmonary hypertension occurred following splenectomy with a change in portal hemodynamics.

Ryuta Shigefuku, Motoh Iwasa, Kyoko Yoshikawa

|Jun 08, 2024
Novel mutation of transferrin receptor 2 causing hereditary hemochromatosis type 3 in a Japanese patient.

Yasuyuki Tamai, Masami Hosotani, Ryuta Shigefuku

|Nov 24, 2021
Prediction of esophagogastric varices associated with oxaliplatin administration.

Yosuke Satta, Ryuta Shigefuku, Tsunamasa Watanabe

|Nov 24, 2021
Update on blood-based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience.

Motoh Iwasa, Ryuta Shigefuku, Akiko Eguchi

Pageof 2

Frequent Collaborators

4 joint publications

Yasuyuki Tamai

2 joint publications

Naoto Fujiwara

2 joint publications

Hayato Nakagawa

1 joint publications

Akiko Eguchi